Podcast

Inside Gamma Delta T Cells With TC BioPharm's CEO, Bryan Kobel

Source: Applied Biosystems by Thermo Fisher Scientific, qPCR
22_01_CGPodcast_1200x628_Ep27

TC BioPharm's CEO Bryan Kobel explains gamma delta T cells (GDT) in depth as well as the advantages of using GDT cells as a cell therapy vehicle. He discusses why the publicly traded, clinical-stage cell therapy company conducts and manages all clinical trials in house as well as the unique challenges and benefits that come along with doing so.

          

 

access the Podcast!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Applied Biosystems by Thermo Fisher Scientific, qPCR